Dr. So is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Palo Alto, CA 94305Phone+1 650-725-6186Fax+1 650-725-9526
Summary
- Dr. Yuen So is a seasoned Neurologist based in Palo Alto, California. His training includes graduation from the Yale School of Medicine and internship and residency at the University of California (San Francisco). He currently is Professor Emeritus at Stanford Department of Neurology and sees patients at Stanford Health Care. Dr. So is experienced in general neurology, electromyography, and neuromuscular medicine. His publication record is robust, with significant works to his credit. Dr. So has received several accolades from his peers and past trainees, including top doctor recognition from Castle Connolly and best teacher awards from each of the 3 academic institutions he has served.
Education & Training
University of California (San Francisco)Residency, Neurology, 1984 - 1988- University of California (San Francisco)Internship, Internal Medicine, 1983 - 1984
Yale School of MedicineClass of 1982
Certifications & Licensure
OR State Medical License 1995 - Present
CA State Medical License 1984 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top Doctor since 2012 Castle Connolly
- Humanism in Medicine Award AAMC - Stanford University, 2005
- Lysia Forno Award for Teaching Excellence Stanford University Department of Neurology, 1999
- Join now to see all
Clinical Trials
- Phenotype, Genotype & Biomarkers in ALS and Related Disorders Start of enrollment: 2015 Apr 01
- A Study for Patients Who Completed VITALITY-ALS (CY 4031) Start of enrollment: 2016 Oct 17
- A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2017 Jul 24
- Join now to see all
Publications & Presentations
PubMed
- 205 citationsSafety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.James F. Howard, Vera Bril, Tuan Vu, Chafic Karam, Stojan Peric
The Lancet. Neurology. 2021-07-01 - 12 citationsMachine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosisKaterina Placek, Michael Benatar, Joanne Wuu, Evadnie Rampersaud, Laura Hennessy
EMBO Molecular Medicine. 2021-01-11 - 23 citationsConsistent improvement with eculizumab across muscle groups in myasthenia gravisRenato Mantegazza, Fanny O'Brien, Marcus Yountz, James F. Howard, Claudio Mazia
Annals of Clinical and Translational Neurology. 2020-08-01
Other
- Wernicke's encephalopathySo YT, Charness ME
http://www.uptodate.com/contents/wernickes-encephalopathy
UpToDate, Wolters Kluwer Health - 2009-11-04
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
